NHS Cancer Performance Data - Phase 6: End-to-End Pipeline Validation
==========================================================================================

ğŸ§ª Starting Phase 6: End-to-End Cancer Data Pipeline Validation
ğŸ“‚ Project directory: /Users/markknapp/Desktop/Projects/NHS-Data-Analytics-Tool-v6-master
ğŸ“‚ Data directory: /Users/markknapp/Desktop/Projects/NHS-Data-Analytics-Tool-v6-master/Data

ğŸ” Test 1: Complete Pipeline Traceability
  ğŸ” Tracing RJ1 data through CWT-CRS-Apr-2024-to-Sep-2024-Data-Extract-Provider-Final.xlsx
    ğŸ“Š Stage 1: Reading Excel data...
    âš™ï¸ Stage 2: Data processing simulation...
    ğŸ—„ï¸ Stage 3: Database verification...
    ğŸ–¥ï¸ Stage 4: Frontend data simulation...
    âŒ Trace failed at stage: consistency
  ğŸ” Tracing RGT data through CWT-CRS-Apr-2024-to-Sep-2024-Data-Extract-Provider-Final.xlsx
    ğŸ“Š Stage 1: Reading Excel data...
    âš™ï¸ Stage 2: Data processing simulation...
    ğŸ—„ï¸ Stage 3: Database verification...
    ğŸ–¥ï¸ Stage 4: Frontend data simulation...
    âŒ Trace failed at stage: consistency
  ğŸ” Traceability success rate: 0.0% (0/2)

ğŸ”„ Test 2: Cross-Stage Data Consistency
    âœ… RJ1 28_day_fds: consistent
    âœ… RJ1 31_day_combined: consistent
    âœ… RJ1 62_day_combined: consistent
    âœ… RGT 28_day_fds: consistent
    âœ… RGT 31_day_combined: consistent
    âœ… RGT 62_day_combined: consistent
    âœ… RBL 28_day_fds: consistent
    âœ… RBL 31_day_combined: consistent
    âœ… RBL 62_day_combined: consistent
  ğŸ”„ Cross-stage consistency: 100.0% (9/9)

ğŸ“Š Test 3: Performance Metrics End-to-End Accuracy
    âœ… RJ1 overall_performance_weighted: 68.8% (calculated: 68.8%)
    âœ… RJ1 total_patients_treated_all_standards: 30841
    âœ… RJ1 total_breaches_all_standards: 6070
    âœ… RGT overall_performance_weighted: 77.4% (calculated: 77.4%)
    âœ… RGT total_patients_treated_all_standards: 28466
    âœ… RGT total_breaches_all_standards: 5282
  ğŸ“Š Metrics accuracy: 100.0% (6/6)

ğŸ¥ Test 4: Trust-Specific Data Validation
  ğŸ¥ Validating trust: RJ1
    âœ… RJ1: validation passed
  ğŸ¥ Validating trust: RGT
    âœ… RGT: validation passed
  ğŸ¥ Validating trust: RBL
    âœ… RBL: validation passed
  ğŸ¥ Validating trust: RTH
    âœ… RTH: validation passed
  ğŸ¥ Trust validation rate: 100.0% (4/4)

ğŸ”„ Test 5: Regression Validation
    âœ… RJ1 28_day_fds: 79.3% (within expected range)
    âœ… RJ1 31_day_combined: 89.2% (within expected range)
    âš ï¸ RJ1 62_day_combined: 52.4% (outside expected 70-90%)
    âœ… RGT 28_day_fds: 85.0% (within expected range)
    âš ï¸ RGT 31_day_combined: 78.3% (outside expected 85-98%)
    âœ… RGT 62_day_combined: 73.8% (within expected range)
  ğŸ”„ Regression validation: 66.7% within expected ranges

ğŸ¯ Test 6: Edge Case Handling
    âœ… zero_totals: handled correctly
    âœ… perfect_performance: handled correctly
    âœ… zero_performance: handled correctly
    âœ… high_volume: handled correctly
  ğŸ¯ Edge case handling: 100.0% (4/4)

ğŸ›¡ï¸ Test 7: Overall System Reliability
    âœ… Database connectivity: reliable (437 records)
    âœ… Data processing: reliable (performance calculation consistent)
    âœ… Data completeness: reliable (100.0% coverage)
  ğŸ›¡ï¸ System reliability: 100.0%
  ğŸ“Š Overall system health: 90.0/100

ğŸ“‹ Generating End-to-End Validation Summary...

======================================================================
ğŸ“‹ PHASE 6 END-TO-END VALIDATION SUMMARY
======================================================================
Pipeline integrity score: 68.0/100
Final confidence level: 57.0%

Confidence breakdown:
  Traceability: 0.0%
  Consistency: 100.0%
  Metrics Accuracy: 100.0%
  System Reliability: 90.0%

Tests: 6/7 passed

Issues found:
  ğŸš¨ Critical: 0
  âš ï¸ High: 1
  â“ Medium: 0
  â„¹ï¸ Low: 1

Overall Status: LOW_CONFIDENCE
Confidence Level: 57.0%

ğŸ“‹ Final Recommendations:
  ğŸš¨ CRITICAL: Very low confidence - major issues must be resolved
  ğŸ”§ Address all high-priority issues to improve data reliability
  ğŸ”„ Improve pipeline integrity before full deployment
  ğŸ“Š Run all phase tests regularly to maintain data accuracy confidence

ğŸ¯ CONFIDENCE INTERPRETATION:
  CRITICAL (<60%): Cancer data accuracy is unacceptable for production use

ğŸ“„ Report saved: /Users/markknapp/Desktop/Projects/NHS-Data-Analytics-Tool-v6-master/data-integrity-tests/phase6_cancer_end_to_end_validation_20250926_081256.json

âš ï¸ Phase 6 end-to-end validation: LOW CONFIDENCE - Significant improvements needed
